[1]
Chaokhamin, I., Attawettayanon, W. , Chalieopanyarwong, V. , Tanthanuch , M. and Bejrananda, T. 2021. Oncological outcomes of metastatic castration resistant prostate cancer (mCRPC) treated with different therapies sequences after completion of docetaxel: a retrospective study in Songklanagarind Hospital. Insight Urology. 42, 2 (Nov. 2021), 131–137. DOI:https://doi.org/10.52786/isu.a.35.